For instance, nearly all existing mouse models for BRCA1-associated breast cancer described earlier are based on co-mutation of Trp53 and Brca1. It might be possible that mutations in yet other genes, such as Pten (Saal et al, 2008), are required to effectively model BRCA1-mutated breast cancer in mice. This evidence concerns the gene PTEN and breast carcinoma.